Journal of Endocrinological Investigation

, Volume 19, Issue 5, pp 284–292 | Cite as

Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy

  • J. Kiljanski
  • C. Stolarski
  • A. Barsouk
  • V. Nebes
  • J. R. Wall


We have studied a possible role of T cell sensitization to eye muscle antigens in patients with thyroid-associated ophthalmopathy (TAO). Peripheral blood mononuclear cell (PBMC) proliferation in response to crude porcine orbital tissue antigens, partially purified porcine eye muscle membrane proteins and predicted epitopic fragments of the recombinant 64 kDa protein 1D, was determined in patients with TAO and thyroid autoimmunity without eye disease. When membrane and cytosol fractions were used as antigen PBMC from 43% of patients with TAO but only 12.5% of normal subjects were responsive to a crude orbital connective tissue membrane fraction, although this difference was not significant. We were unable to demonstrate specific recognition of partially purified eye muscle membrane fractions; although most of the fractions tested were occasionally recognized by T cells from patients with ophthalmopathy, this was also the case for patients with autoimmune thyroid disease without ophthalmopathy and normal subjects. We did not clearly identify epitopic sequences within the 1D protein, most of the predicted peptides tested being recognized not only by T cells from a small proportion of patients with TAO, but also by those from some patients with autoimmune thyroid disease without ophthalmopathy and normal subjects. It is noteworthy however that approximately 22% of TAO patients, but no normal subjects, were positive to one or more of three peptides, suggesting that reactivity to the 1D protein may play a role in the pathogenesis of the eye disorder in some patients with TAO. The inconsistent and generally low T cell responses to crude and purified antigens noted in a few patients with TAO could be explained by low numbers of specifically sensitized lymphocytes in peripheral blood.


Thyroid-associated ophthalmopathy graves’ disease eye muscle orbital connective tissue T cell epitope 1D protein 64 kDa protein 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Burch H.B., Wartofsky L. Graves’ Ophthalmopathy: Current Concepts Regarding Pathogenesis and Management. Endoer. Rev. 14: 747, 1993.Google Scholar
  2. 2.
    Kiljanski J., Nebes V., Wall J.R. Is the ocular muscle a target of the immune system in endocrine ophthalmopathy. Pro. Intl. Arch. Allergy Immunol., 106: 204, 1995.CrossRefGoogle Scholar
  3. 3.
    Salvi M., Miller A., Wall J.R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett. 232: 135, 1988.PubMedCrossRefGoogle Scholar
  4. 4.
    Miller A., Arthurs B., Boucher A., Liberman A., Bernard N., Rodien P., Salvi M., Wall J.R. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity. Thyroid 2: 197, 1992.PubMedCrossRefGoogle Scholar
  5. 5.
    Salvi M., Bernard N., Miller A., Zhang Z.G., Gardini E., Wall J.R. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1: 204, 1991.CrossRefGoogle Scholar
  6. 6.
    Wall J.R., Bernard N., Boucher A., Salvi M., Zhang Z.G., Kennerdell J., Tyutyunikov A., Genovese C. Pathogenesis of thyroid-associated ophthalmopathy: An autoimmune disorder of the eye muscle associated with Graves’ hyperthyroidism and Hashimoto’s thyroiditis. Clin. Immunol. Immunopathol. 68: 1, 1993.PubMedCrossRefGoogle Scholar
  7. 7.
    Dong Q., Ludgate M., Vassart G. Cloning and sequencing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 92: 1375, 1991.CrossRefGoogle Scholar
  8. 8.
    Bernard N.F., Salvi M., Tyutyunikov A., Genovese C., Ludgate M., Wall J.R. Antibodies against the recombinant 64 kDa membrane protein 1D are associated with ophthalmopathy in patients with thyroid autoimmunity. Clin. Immunol. Immunopath. 70: 225, 1994.CrossRefGoogle Scholar
  9. 9.
    Cornette J.L, Margalit H., DeLisi C, Berzofsky J.A. Identification of T-cell epitopes and use in construction of synthetic vaccine. Methods in Enzymology 178: 611, 1989.PubMedCrossRefGoogle Scholar
  10. 10.
    Berzofsky J.A. Mechanisms of T cell recognition with application to vaccine design. Mol. Immunol. 28: 217, 1991.PubMedCrossRefGoogle Scholar
  11. 11.
    Margalit H., Spouge J.L., Cornette K., Cease K., DeLisi C, Berzofsky J.A. Prediction of immunodominant helper T-cell antigenic sites from the primary sequence. J. Immunol. 138: 2213, 1987.PubMedGoogle Scholar
  12. 12.
    Committees of Regional Thyroid Association. Classification of eye changes of Graves’ disease. Thyroid 2: 235, 1992.CrossRefGoogle Scholar
  13. 13.
    Wall J.R., Strakosch CR., Fang S.L., Ingbar S.H., Braverman L. Thyroid binding antibodies and other immunological abnormalities in patients with Graves’ ophthalmopathy: Effect of treatment with cyclophosphamide. Clin. Endocrinol. 10: 79, 1979.CrossRefGoogle Scholar
  14. 14.
    Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680, 1970.PubMedCrossRefGoogle Scholar
  15. 15.
    Wall J.R. Nature and significance of eye muscle autoantigens in endocrine ophthalmopathy. In: Kahaly G. (Ed), Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Dev. Ophthalmol. Basel, Karger, 25, 1993, p. 77.Google Scholar
  16. 16.
    Tallstedt L, Norberg R. Immunohistochemical staining of normal and Graves’ extraocular muscle. Vestigative Ophthalmology and Visual Science 29: 175, 1988.Google Scholar
  17. 17.
    Weetman A.P., Cohen S., Gatter K.C., Fells P., Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves’ ophthalmopathy. Clin. Exp. Immunology 75: 222, 1989.Google Scholar
  18. 18.
    Bahn R.S., Heufelder A.E. Orbital connective tissue in endocrine ophthalmopathy. In: Kahaly G. (Ed.), Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Dev. Ophthalmol. Karger, Basel, 25: 46, 1993.Google Scholar
  19. 19.
    Hiromatsu Y., Fukazawa H., How J., Wall J.R. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves’ ophthalmopathy — roles of Class II MHC antigen expression and n-interferon action on effector and target cells. Clin. Exp. Immunol. 70: 593, 1987.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Hiromatsu Y., Tanaka K., Ishisaka N., Nonaka K., Hoshino T., Inoue Y. HLA-DR antigen expression on eye muscle in thyroid-associated ophthalmopathy. In: Nagataki S., Mori T., Torizuka K. (Eds.), 80 years of Hashimoto Disease. Excerpta Medica Elsevier Science Publishers B.V., 1993, p. 349.Google Scholar
  21. 21.
    Rosen C, Raikow R.B., Bürde R.M., Kennerdell J.S., Mosseri M., Scalise D. Immunohistochemical evidence for IgGAI involvement in Graves’ ophthalmopathy. Ophthalmol. 99: 146, 1992.CrossRefGoogle Scholar
  22. 22.
    Arnold K., Tandon N., Macintosh R.S., Ludgate M., Weetman A.P. T cell responses to orbital antigens inn thyroid-associated ophthalmopathy. Clin. Exp. Immunol. 96: 329, 1994.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Wall J.R., Scalise D., Hayes M., Stolarski C, Sato M., Salvi M., Nebes V. Native gel electrophoresis of the 64 kDa protein shows that is eye muscle specific and an important target for autoantibodies in patients with thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 80: 1226, 1995.PubMedGoogle Scholar
  24. 24.
    Ross P.V., Koenjg R.J., Arscott P., Ludgate M., Waier M., Nelson C.C., Kaplan M., Baker J.R. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 77: 433, 1993.PubMedGoogle Scholar
  25. 25.
    Tandon N., Weetman A.P.O. T cells and thyroid autoimmunity. J. R. Coll. Physicians Lond. 28: 10, 1994.PubMedGoogle Scholar
  26. 26.
    Arnold K., Weetman A.P. Cell-mediated immunity in thyroid-associated ophthalmopathy. Orbit (In press).Google Scholar
  27. 27.
    McLachlan S.M., Proud G., Pegg C.A., Clark F., Rees-Smith B. Functional analysis of T and B cells from blood and thyroid tissue in Hashimoto’s disease. Clin. Exp. Immunol. 59: 585, 1985.PubMedCentralPubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1996

Authors and Affiliations

  • J. Kiljanski
    • 1
    • 2
  • C. Stolarski
    • 1
  • A. Barsouk
    • 1
  • V. Nebes
    • 1
  • J. R. Wall
    • 1
  1. 1.Thyroid Eye Disease Research ProgramAllegheny-Singer Research InstitutePittsburghUSA
  2. 2.Department of Endocrinology, Medical Research CenterPolish Academy of SciencesWarsawPoland

Personalised recommendations